EXAGEN INC. Other Non-Current Liabilities
EXAGEN INC. (XGN) had Other Non-Current Liabilities of $91.00 thousand as of 2025-06-30, per its 10-Q filed 2025-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-07-29
- 2025-06-30: Other Liabilities, Noncurrent $91.00K.
- 2025-03-31: Other Liabilities, Noncurrent $122.00K.
- 2024-12-31: Other Liabilities, Noncurrent $157.00K.
- 2024-09-30: Other Liabilities, Noncurrent $185.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-06-30 | $91.00K 10-Q · filed 2025-07-29 |
| 2025-03-31 | $122.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $157.00K 10-Q · filed 2025-07-29 |
| 2024-09-30 | $185.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $219.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $268.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $357.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $484.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $597.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $726.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $867.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $999.00K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $810.00K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $763.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.41M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.43M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.15M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $948.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $645.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $521.00K 10-Q · filed 2020-07-28 |
| 2020-03-31 | $581.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $638.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $510.00K 10-Q · filed 2019-11-12 |
| 2018-12-31 | $304.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |